I hope it works for you. I've been on WA1 since the day they announced the discovery so no fomo for me. If they do make a discovery here it could be the case it becomes fully priced through the discovery phase as AZS was. WA1 was supper cheap when it opened at 22c on 26/10/22 but I feel like some people knew things others didn't. (eg the over limit assays at Luni) However the opportunity at from Jan-April 2023 was incredible. They'd drilled a bunch of holes and it was trading at a mkt cap of $50-75M and up to at least 40% discount to the at premium raise price. you just have to to back yourself. At the time I was saying it should be worth at least $300M. I think RCR is fully if not a little underpriced still but I think the investors will reward the company with a cap raise soon.
